A61K 9/19
Lyophilised , i.e. freeze-dried, solutions or dispersions
Official title: lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)}
A61K9/19 (Lyophilised , i.e. freeze-dried, solutions or dispersions) appears on 3,296 US grants and 6,207 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,296
- Published applications
- 6,207
- Assignees
- 2,546
- Inventors
- 10,992
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 5 | 0 |
| 1983 | 2 | 0 |
| 1984 | 5 | 0 |
| 1985 | 8 | 0 |
| 1986 | 5 | 0 |
| 1987 | 7 | 0 |
| 1988 | 5 | 0 |
| 1989 | 9 | 0 |
| 1990 | 7 | 0 |
| 1991 | 10 | 0 |
| 1992 | 5 | 0 |
| 1993 | 11 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 7 | 0 |
| 1997 | 13 | 0 |
| 1998 | 17 | 0 |
| 1999 | 19 | 0 |
| 2000 | 13 | 0 |
| 2001 | 21 | 10 |
| 2002 | 16 | 35 |
| 2003 | 20 | 58 |
| 2004 | 23 | 73 |
| 2005 | 18 | 96 |
| 2006 | 36 | 116 |
| 2007 | 29 | 118 |
| 2008 | 31 | 142 |
| 2009 | 40 | 154 |
| 2010 | 67 | 234 |
| 2011 | 74 | 191 |
| 2012 | 103 | 179 |
| 2013 | 141 | 188 |
| 2014 | 159 | 246 |
| 2015 | 153 | 289 |
| 2016 | 145 | 300 |
| 2017 | 186 | 328 |
| 2018 | 188 | 292 |
| 2019 | 203 | 393 |
| 2020 | 244 | 458 |
| 2021 | 215 | 440 |
| 2022 | 223 | 437 |
| 2023 | 204 | 412 |
| 2024 | 231 | 374 |
| 2025 | 220 | 382 |
| 2026 | 134 | 262 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Protease composition6 Oct 2026US 12,751,997 B2Anatara Lifesciences Limited
- Notch signaling inhibitors for treating obesity and metabolic disorders22 Sep 2026US 12,740,989 B2Purdue Research Foundation
- Preparation including vaccine adjuvant22 Sep 2026US 12,741,021 B2Sumitomo Dainippon Pharma Co., Ltd.
- Exosomes comprising coronavirus-derived antigen protein or gene encoding same protein, and use of same8 Sep 2026US 12,728,154 B2Ewha University-Industry Collaboration Foundation
- Stable lyophilized composition of pemetrexed dipotassium1 Sep 2026US 12,721,811 B1AVYXA Pharma
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Platelet derivative compositions, and methods of making and using such compositions8 Oct 2026US 2026/0306545 A1Cellphire, Inc.
- Production of a probiotic composition8 Oct 2026US 2026/0306558 A1Blis Technologies Limited
- Process and formulation of lipid nanoparticles8 Oct 2026US 2026/0306584 A1Translate Bio, Inc.
- Stabilized liquid and lyophilized adamts13 formulations8 Oct 2026US 2026/0306593 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Drug-delivering composite structures814US 9,446,226 B2Ramot at Tel-Aviv University Ltd. · 2016
- Frozen piercing implements and methods for piercing a substrate284US 8,784,385 B2The Invention Science Fund I, LLC · 2014
- Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof257US 5,916,596 AVivorx Pharmaceuticals, Inc. · 1999
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Protein formulation234US 6,685,940 B2Genentech, Inc. · 2004